Patents by Inventor Mark Hokenson

Mark Hokenson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABILIZATION OF CANNABINOIDS WITHIN SOLID DOSAGE FORMS
    Publication number: 20240009208
    Abstract: The use of phosphatidylcholines to directly stabilize cannabinoids within dry powder is described. Phosphatidylcholines include 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and cannabinoids include tetrahydrocannabinol (THC) and cannabidiol (CBD). The dry powder containing the stabilized cannabinoids can be formulated for inhalation or oral delivery. Dry powder formulated for inhalation can include formyl diketopiperazine (FDKP). Oral delivery of the dry powder containing the stabilized cannabinoids includes delivery to the gastrointestinal tract and to the mucous membranes of the oral cavity.
    Type: Application
    Filed: October 1, 2021
    Publication date: January 11, 2024
    Applicant: RECEPTOR HOLDINGS, INC.
    Inventors: Kelly Kraft, Mark Hokenson
  • METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
    Publication number: 20230390206
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Application
    Filed: August 18, 2023
    Publication date: December 7, 2023
    Applicant: MANNKIND Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
    Publication number: 20210353544
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Application
    Filed: July 26, 2021
    Publication date: November 18, 2021
    Applicant: MannKind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
    Patent number: 11103459
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: August 31, 2021
    Assignee: MannKind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
    Publication number: 20190029961
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Application
    Filed: October 4, 2018
    Publication date: January 31, 2019
    Inventors: Mark Hokenson, Keith A. Oberg
  • Method of drug formulation
    Patent number: 10143655
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: December 4, 2018
    Assignee: MannKind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
    Publication number: 20160346212
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Application
    Filed: August 10, 2016
    Publication date: December 1, 2016
    Inventors: Mark Hokenson, Keith A. Oberg
  • Increasing drug affinity for crystalline microparticle surfaces
    Patent number: 9446001
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: September 20, 2016
    Assignee: MannKind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
    Publication number: 20150359744
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Application
    Filed: June 22, 2015
    Publication date: December 17, 2015
    Inventors: Mark Hokenson, Keith A. Oberg
  • Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
    Patent number: 9089497
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Grant
    Filed: September 16, 2010
    Date of Patent: July 28, 2015
    Assignee: MannKind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
    Patent number: 9066881
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: June 30, 2015
    Assignee: MannKind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • Method of drug formulation of compositions comprising crystalline microparticle surfaces
    Patent number: 8420604
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Grant
    Filed: June 14, 2010
    Date of Patent: April 16, 2013
    Assignee: Mannkind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
    Publication number: 20110003004
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Application
    Filed: September 16, 2010
    Publication date: January 6, 2011
    Applicant: Mannkind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
    Publication number: 20100247661
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Application
    Filed: June 14, 2010
    Publication date: September 30, 2010
    Applicant: MannKind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
    Patent number: 7803404
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: September 28, 2010
    Assignee: MannKind Corporation
    Inventors: Mark Hokenson, Keith A. Oberg
  • Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
    Publication number: 20070059374
    Abstract: Methods are provided for promoting the adsorption of an active agent to microparticles by modifying the structural properties of the active agent in order to facilitate favorable association to the microparticle.
    Type: Application
    Filed: September 14, 2006
    Publication date: March 15, 2007
    Inventors: Mark Hokenson, Keith Oberg